ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating ICU Medical, Inc. for potential violations of securities laws related to misleading statements and undisclosed information affecting investors [1][2]. Group 1: Investigation Details - The investigation centers on whether ICU Medical issued false or misleading statements and failed to disclose critical information to investors [2]. - An FDA warning letter dated April 22, 2025, highlighted that ICU Medical made multiple changes to its Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump, which could significantly impact the safety and effectiveness of these devices [2]. - The FDA classified the pumps as "adulterated" and "misbranded," indicating that modifications could significantly affect functionality, including infusion delivery profiles and alarm functionality, thereby altering the risk profile of the devices [2].